BOTHELL, Wash.--(BUSINESS WIRE)--ICOS Corporation (NASDAQ: ICOS), announced today that Glass Lewis and Company, a leading proxy advisory service, has issued its report recommending that ICOS’ shareholders vote in favor of the revised offer by Eli Lilly and Company (NYSE:LLY) to acquire all of the outstanding common stock of ICOS for a purchase price of $34 per share in cash. PROXY Governance Inc., another proxy advisory service, also has recommended that shareholders vote to approve the offer.
